Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02567656
Title Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in T-cell Lymphoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Rhizen Pharmaceuticals SA
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
Chao Family Comprehensive Cancer Center University of California Irvine Orange California 92868 United States Details
University of Colorado Cancer Center Aurora Colorado 80045 United States Details
Emory University School of Medicine Atlanta Georgia 30322 United States Details
University of Michigan Comprehensive Cancer Center Ann Arbor Michigan 48109-0944 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
University Hospitals Cleveland Medical Center Cleveland Ohio 44106-5028 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from for the field